1. "Neuroradiology Service"
  2. "David Pfister"
  3. "American Society of Clinical Oncology"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (4)
Groups
  1. Department of Medicine (37)
  2. Head and Neck Service (37)
  3. Neuroradiology Service (37)
  4. Radiology, Department of (37)
  5. Solid Tumor Oncology Division (37)
  6. Biostatistics Service (16)

More Groups

People
  1. David Pfister (37)
  2. Eric Sherman (32)
  3. Sofia Haque (28)
  4. Alan Ho (25)
  5. Matthew Fury (17)
  6. Lara Dunn (15)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (3)
  4. 2021 (2)
  5. 2020 (2)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (37)
Publishers
  1. American Society of Clinical Oncology (37)

Results (37)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hypoxia-directed treatment of human papillomavirus-related oropharyngeal carcinoma
    Journal Article

    Lee, N. Y.; Sherman, E. J.; Schòˆder, H.; Wray, R.; Boyle, J. O.; Singh, B.; Grkovski, M.; Paudyal, R.; Cunningham, L.; Zhang, Z.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Wong, W.; Cracchiolo, J. R.; Riaz, N.; Ganly, I.; Sherman, E. J.; Ho, A. L.; Morris, L.; Ghossein, R. A.; Haque, S.; Hung, K. W.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A pilot study of trametinib in combination with paclitaxel in the treatment of anaplastic thyroid cancer
    Meeting Abstract

    Sherman, E. J.; Michel, L. S.; Kriplani, A.; Dunn, L.; Haque, S.; Bang, D.; Stein, S.; Pfister, D. G.; Ho, A. L.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Ho, A. L.; Ganly, I.; Riaz, N.; Morris, L.; Hung, K. W.; Kriplani, A.; Cracchiolo, J. R.; Cohen, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic salivary gland cancers (R/M SGCs)
    Meeting Abstract

    Burman, B.; Sherman, E. J.; Dunn, L.; Fetten, J. V.; Michel, L. S.; Morris, L. G. T.; Ostrovnaya, I.; Haque, S.; Pfister, D. G.; Ho, A. L.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Randomized phase II trial of nivolumab with stereotactic body radiotherapy versus nivolumab alone in metastatic head and neck squamous cell carcinoma
    Journal Article

    McBride, S.; Sherman, E.; Tsai, C. J.; Baxi, S.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D.; Michel, L. S.; Young, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase I/Ib study of lenvatinib and cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Ho, A. L.; Eng, J.; Michel, L. S.; Fetten, J. V.; Warner, E.; Kriplani, A.; Zhi, W. I.; Ng, K. K.; Haque, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers
    Meeting Abstract

    Burman, B.; Sherman, E. J.; Kriplani, A.; Michel, L. S.; Dunn, L.; Fetten, J. V.; Warner, E.; Grewal, R. K.; Sabra, M.; Tuttle, R. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic adenoid cystic carcinoma (R/M ACC)
    Meeting Abstract

    Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Morris, L.; Ostrovnaya, I.; Katabi, N.; Haque, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save